导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -6.13% | 737/1046 |
| 近一周 | -2.06% | 433/1100 |
| 近一月 | -1.93% | 215/1098 |
| 近一季 | -2.48% | 346/1088 |
| 近半年 | -3.65% | 551/1066 |
| 近一年 | -10.84% | 751/1016 |
| 近两年 | 49.44% | 510/924 |
| 近三年 | 46.80% | 274/834 |
| 成立以来 | 30.85% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.61% 851/1070 |
-5.70% 817/1101 |
- - |
- - |
| 2025 | 31.67% 449/1065 |
16.11% 42/1014 |
6.37% 222/1038 |
14.07% 764/1050 |
-6.54% 775/1065 |
| 2024 | 27.52% 34/1011 |
0.56% 286/960 |
8.23% 30/983 |
16.16% 167/991 |
0.86% 279/1011 |
| 2023 | -6.00% 224/952 |
2.23% 495/880 |
0.94% 138/895 |
-5.09% 315/915 |
-4.03% 411/952 |
| 2022 | -9.57% 82/867 |
-10.46% 120/773 |
5.47% 493/806 |
-13.84% 506/845 |
11.13% 65/867 |
| 2021 | -15.72% 519/740 |
-0.23% 161/580 |
1.84% 518/659 |
-10.10% 510/704 |
-7.74% 630/740 |
| 2020 | 9.51% 398/554 |
-13.73% 402/419 |
10.54% 396/466 |
1.40% 406/517 |
13.26% 244/554 |
| 2019 | 13.16% 340/410 |
9.59% 1057/1149 |
0.09% 327/1231 |
-4.72% 371/390 |
8.28% 226/410 |
| 2018 | - - |
- - |
- - |
- - |
-8.43% 176/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 富国港股通量化精选股票A VS. 东吴新产业精选股票A(580008) |